Dialysis Facilities in Mishawaka, Indiana
3 dialysis facilities found, showing 1 - 3
 FMC - Nephrology - Mishawaka Chain: Fresenius Medical Care Location: 710 Park Place, Mishawaka, Indiana, 46545 Rating: Phone: (574) 273-6776 |
FMC - Nephrology - Home Chain: Fresenius Medical Care Location: 250 E. Day Road, Suite 300, Mishawaka, Indiana, 46545 Rating: Not Available Phone: (574) 273-6777 |
Davita - Mishawaka Dialysis Chain: Davita Location: 1420 Trinity Place, Mishawaka, Indiana, 46545 Rating: Phone: (574) 231-7204 |
News Archive
FDA approves limited use of artificial heart
The Food and Drug Administration (FDA) in the United States has given approval for limited use of an artificial heart.
VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds
Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).
KIYATEC's test results accurately predict treatment response in recurrent high-grade glioma patients
KIYATEC, Inc. announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM) and other high-grade glioma (HGG) patients.
CHI releases new white paper on 510(k) review process
California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
ImmunoCellular provides update on ICT-107 Phase II trial for glioblastoma multiforme
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, provided an update today on clinical trial site activity and patient enrollment for its Phase II clinical trial of ICT-107, the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme.
› Verified 8 days ago
Dialysis Facility
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
Medicare Star Ratings
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.